标题
The immune landscape of esophageal cancer
作者
关键词
-
出版物
Cancer Communications
Volume 39, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-26
DOI
10.1186/s40880-019-0427-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy
- (2019) Yujie Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Stromal-derived interleukin 6 drives epithelial-to-mesenchymal transition and therapy resistance in esophageal adenocarcinoma
- (2019) Eva A. Ebbing et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy
- (2019) Sha Zhou et al. Cancers
- The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma
- (2019) Heike Loeser et al. OncoImmunology
- Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma
- (2019) Nobuhide Higashino et al. LABORATORY INVESTIGATION
- Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal Cancer
- (2019) Andrew E. Blum et al. GASTROENTEROLOGY
- The emerging role of immunotherapy for esophageal cancer
- (2019) Ronan J. Kelly CURRENT OPINION IN GASTROENTEROLOGY
- Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer
- (2019) Taisuke Yagi et al. EUROPEAN JOURNAL OF CANCER
- Adaptive plasticity of IL-10+ and IL-35+ Treg cells cooperatively promotes tumor T cell exhaustion
- (2019) Deepali V. Sawant et al. NATURE IMMUNOLOGY
- Prognostic impact of tumor-associated macrophage infiltration in esophageal cancer: a meta-analysis
- (2019) Jiangfen Li et al. Future Oncology
- Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
- (2019) Yuhong Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of exosomes in tumour and transplant immune regulation
- (2019) Diego A. Lema et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Immunomodulatory TGF-β Signaling in Hepatocellular Carcinoma
- (2019) Jian Chen et al. TRENDS IN MOLECULAR MEDICINE
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- A good start of immunotherapy in esophageal cancer
- (2019) Qian Zhao et al. Cancer Medicine
- Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinoma
- (2019) Qin Tan et al. Journal for ImmunoTherapy of Cancer
- IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer
- (2018) Yuki Kiyozumi et al. ANNALS OF SURGERY
- Evolving Roles for Targeting CTLA-4 in Cancer Immunotherapy
- (2018) Yinghao Zhao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
- (2018) Jing Huang et al. CLINICAL CANCER RESEARCH
- Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8+ T cell response in esophageal squamous cell carcinoma
- (2018) Xinfeng Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical significance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas
- (2018) Anjali Vinocha et al. Journal of Cancer Research and Therapeutics
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
- (2018) Taigo Kato et al. Oncotarget
- EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
- (2018) Hui Shi et al. Journal of Thoracic Disease
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer
- (2018) Yelena Y. Janjigian et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
- (2018) Xian Shen et al. BMJ-British Medical Journal
- PD-L2 Expression as a Potential Predictive Biomarker for the Response to Anti-PD-1 Drugs in Patients with Non-small Cell Lung Cancer
- (2018) SHINKICHI TAKAMORI et al. ANTICANCER RESEARCH
- NY-ESO-1 antigen expression and immune response are associated with poor prognosis in MAGE-A4-vaccinated patients with esophageal or head/neck squamous cell carcinoma
- (2018) Shugo Ueda et al. Oncotarget
- Gene set enrichment analysis and meta-analysis to identify six key genes regulating and controlling the prognosis of esophageal squamous cell carcinoma
- (2018) Wenwu He et al. Journal of Thoracic Disease
- A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
- (2018) Jingjing Duan et al. Journal for ImmunoTherapy of Cancer
- Cancer immunotherapy targeting the CD47/SIRPα axis
- (2017) Kipp Weiskopf EUROPEAN JOURNAL OF CANCER
- Deficiency of IL-18 Aggravates Esophageal Carcinoma Through Inhibiting IFN-γ Production by CD8+T Cells and NK Cells
- (2017) Jiantao Li et al. INFLAMMATION
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment
- (2017) Miao-Fen Chen et al. MOLECULAR CARCINOGENESIS
- Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
- (2017) Vinod P. Balachandran et al. NATURE
- Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation
- (2017) Dong Liu et al. ONCOLOGY REPORTS
- Targeting CD47 Enhances the Efficacy of Anti-PD-1 and CTLA-4 in an Esophageal Squamous Cell Cancer Preclinical Model
- (2017) Hua Tao et al. ONCOLOGY RESEARCH
- The Current Status of Immunotherapies in Esophagogastric Cancer
- (2017) Geoffrey Y. Ku Surgical Oncology Clinics of North America
- Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer
- (2017) Susanne Blank et al. Oncotarget
- The Dynamic and Transient Immune Microenvironment in Locally Advanced Esophageal Adenocarcinoma Post Chemoradiation
- (2017) Ronan J. Kelly et al. ANNALS OF SURGERY
- Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray
- (2016) Meixiang Sang et al. ARCHIVES OF MEDICAL RESEARCH
- Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
- (2016) Fergus Noble et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3–CCL2 Signaling
- (2016) Xuguang Yang et al. CANCER RESEARCH
- Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
- (2016) Bernhard Mlecnik et al. IMMUNITY
- Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
- (2016) Nayoung Lee et al. PATHOLOGY
- Dendritic Cells and Cancer Immunity
- (2016) Alycia Gardner et al. TRENDS IN IMMUNOLOGY
- Comprehensive immunohistochemical analysis of tumor microenvironment immune status in esophageal squamous cell carcinoma
- (2016) Ken Hatogai et al. Oncotarget
- Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation
- (2016) J-t Cheng et al. Oncogenesis
- CTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma
- (2015) J Y Liu et al. BRITISH JOURNAL OF CANCER
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer
- (2015) T. A. Karakasheva et al. CANCER RESEARCH
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Esophageal cancer-derived microvesicles induce regulatory B cells
- (2015) Yun Li et al. CELL BIOCHEMISTRY AND FUNCTION
- Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer
- (2015) S. Kageyama et al. CLINICAL CANCER RESEARCH
- Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma
- (2015) Shinya Ohashi et al. GASTROENTEROLOGY
- Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts
- (2015) Inga Kretschmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers
- (2015) Yoko Oshima et al. JOURNAL OF GASTROENTEROLOGY
- Quantification of tumor infiltrating Foxp3+ regulatory T cells enables the identification of high-risk patients for developing synchronous cancers over upper aerodigestive tract
- (2015) Wen-Lun Wang et al. ORAL ONCOLOGY
- Circulating CD14+HLA-DR−/low myeloid-derived suppressor cell is an indicator of poor prognosis in patients with ESCC
- (2015) Haitao Huang et al. TUMOR BIOLOGY
- Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma
- (2015) S. Derks et al. Cancer Immunology Research
- Effects of Thermotherapy on Th1/Th2 Cells in Esophageal Cancer Patients Treated with Radiotherapy
- (2014) Mei Hong et al. Asian Pacific Journal of Cancer Prevention
- Regulatory T cells in cancer immunotherapy
- (2014) Hiroyoshi Nishikawa et al. CURRENT OPINION IN IMMUNOLOGY
- Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients
- (2014) Hisae Iinuma et al. Journal of Translational Medicine
- Neoantigen in esophageal squamous cell carcinoma for dendritic cell-based cancer vaccine development
- (2014) Mohammad Mahdi Forghanifard et al. MEDICAL ONCOLOGY
- Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation
- (2014) Simona Hefetz-Sela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of the anti-tumour immune response by cancer-associated fibroblasts
- (2014) James Harper et al. SEMINARS IN CANCER BIOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival
- (2013) Lin Lu et al. JOURNAL OF IMMUNOTHERAPY
- Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
- (2013) Shinichi Kageyama et al. Journal of Translational Medicine
- Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens
- (2012) Koji Kono et al. Journal of Translational Medicine
- Increased IL-17-producing CD4+ T cells in patients with esophageal cancer
- (2011) Deyu Chen et al. CELLULAR IMMUNOLOGY
- MAGE-A3/4 and NY-ESO-1 antigens expression in metastatic esophageal squamous cell carcinoma
- (2011) T. Bujas et al. EUROPEAN JOURNAL OF HISTOCHEMISTRY
- Expression Pattern of Immune Suppressive Cytokines and Growth Factors in Oesophageal Adenocarcinoma Reveal a Tumour Immune Escape-promoting Microenvironment
- (2010) F. Milano et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
- (2009) Koji Kono et al. CANCER SCIENCE
- Overexpression and Interactions of Interleukin-10, Transforming Growth Factor β, and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma
- (2009) Mehran Gholamin et al. WORLD JOURNAL OF SURGERY
- Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma
- (2008) T Yoshioka et al. BRITISH JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search